Bionano Genomics (BNGO) EBITDA margin US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | -410.7% | -432.8% | -591.4% | -316.7% | -57.2% | -81.0% | ||
| Changes by years, y/y, % | +8pp | -22pp | -159pp | +275pp | +260pp | -32.8% | |||
Bionano Genomics. EBITDA margin, %
Bionano Genomics. EBITDA margin, changes, pp
Bionano Genomics (BNGO) EBITDA margin US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| EBITDA margin, % | ? | -92.6% | -66.0% | -81.3% | -68.4% | -87.6% | -81.0% | |
| Changes by years, y/y, % | +177pp | +98pp | +552pp | +148pp | +5pp | |||
| Changes by quarters, q/q, % | +124pp | +27pp | -15pp | +13pp | -19pp | |||